A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis-Reference-Cited by-同舟云学术

A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis

Published:2019-02 Issue:2 Volume:9 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer Journal

Author:

Sharpley Faye A.,Manwani Richa,Mahmood Shameem,Sachchithanantham Sajitha,Lachmann Helen J.,Gillmore Julian D.,Whelan Carol J.,Fontana Marianna,Hawkins Philip N.,Wechalekar Ashutosh D.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

http://www.nature.com/articles/s41408-019-0180-1.pdf

Reference5 articles.

1. Milani, P. et al. The utility of MASS-FIX to detect and monitor monoclonal proteins in the clinic. Am. J. Hematol. 92, 772–779 (2017).

2. Barnidge, D. R. et al. Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC-MS/MS. J. Proteome Res. 13, 1905–1910 (2014).

3. Bergen, H. R. 3rd et al. Clonotypic light chain peptides identified for monitoring minimal residual disease in multiple myeloma without bone marrow aspiration. Clin. Chem. 62, 243–251 (2016).

4. Mills, J. R. et al. Comprehensive assessment of M-proteins using nanobody enrichment coupled to MALDI-TOF mass spectrometry. Clin. Chem. 62, 1334–1344 (2016).

5. Gertz, M. A. et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am. J. Hematol. 79, 319–328 (2005).

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein-Centric Analysis of Personalized Antibody Repertoires Using LC-MS-Based Fab-Profiling on a timsTOF;Journal of the American Society for Mass Spectrometry;2024-04-25

2. AL amyloidosis response: a move in the “light” direction;Blood;2024-03-28

3. Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis;Blood;2024-03-28

4. Progression free survival of myeloma patients who become IFE-negative correlates with the detection of residual monoclonal free light chain (FLC) by mass spectrometry;Blood Cancer Journal;2024-03-18

5. Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies;Antibodies;2024-03-11